EPRATUZUMAB
UNII 3062P60MH9

Substance Identification & Data

This profile provides standardized clinical and technical data for Epratuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3062P60MH9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 205923-57-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3062P60MH9

CAS Registry Number

205923-57-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EPRATUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C1887

National Cancer Institute reference terminology for clinical and research data.

INN ID

7920

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KK-47

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Epratuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EPRATUZUMAB

Common Names & Synonyms

EPRATUZUMAB [INN]

EPRATUZUMAB [MART.]

EPRATUZUMAB [MI]

EPRATUZUMAB [USAN]

EPRATUZUMAB [WHO-DD]

IMMUNOGLOBULIN G (HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .GAMMA.-CHAIN ANTI-HUMAN ANTIGEN CD22), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G (HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .GAMMA.-CHAIN ANTI-HUMAN ANTIGEN CD22), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G, ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G, ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL HLL2 .GAMMA.-CHAIN ANTI-HUMAN ANTIGEN CD22), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HLL2 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL HLL2 .GAMMA.-CHAIN ANTI-HUMAN ANTIGEN CD22), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HLL2 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HLL2 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HLL2 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HLL2 .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HLL2 .KAPPA.-CHAIN, DIMER